Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27237559 | 1.00 | CPB2 (0.30) | CPB2 | |
| SCHEMBL1396737 | 0.84 | CYP1A2 (0.31) | — | |
| SCHEMBL1245229 | 0.81 | — | — | |
| Propionic Acid SCHEMBL1044207 | 0.81 | — | — | |
| SCHEMBL31141331 | 0.81 | IDO1 (0.32) | — | |
| SCHEMBL2735995 | 0.81 | IDO1 (0.32) | — | |
| SCHEMBL13209034 | 0.81 | IDO1 (0.32) | — | |
| SCHEMBL1396689 | 0.81 | IDO1 (0.32) | — | |
| SCHEMBL6774632 | 0.80 | CDC25A (0.35) | — | |
| Cyclopropane Carboxylic Acid SCHEMBL3008327 | 0.80 | APLNR (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250302728-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2025-10-02 | — | — | US | claimed |
| US-20240197243-A1 | FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2024-06-20 | — | — | US | claimed |
| EP-4347757-A1 | FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | Givaudan SA (CH) | 2024-04-10 | — | — | EP | claimed |
| CN-117396590-A | Perfume for improving relaxation state and evaluation method | 奇华顿股份有限公司 | 2024-01-12 | — | — | CN | claimed |
| WO-2023224604-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2023-11-23 | — | — | WO | claimed |
| WO-2023222753-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2023-11-23 | — | — | WO | claimed |
| WO-2022234149-A1 | FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2022-11-10 | — | — | WO | claimed |
| US-10947483-B2 | Encapsulates | PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA (CH) | 2021-03-16 | — | — | US | claimed |
| CN-106999893-B | Method for encapsulating active substances in droplets and other compartments | 宝洁公司 | 2020-07-14 | — | — | CN | claimed |
| US-10604728-B2 | Encapsulates | PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA (CH) | 2020-03-31 | — | — | US | claimed |
| US-20160304817-A1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2016-10-20 | — | — | US | claimed |
| WO-2016085740-A1 | COMPOSITIONS COMPRISING ENCAPSULATED ACTIVES WITHIN DROPLETS AND OTHER COMPARTMENTS | THE PROCTER & GAMBLE COMPANY (US) | 2016-06-02 | — | — | WO | claimed |
| WO-2016085742-A1 | METHODS FOR ENCAPSULATION OF ACTIVES WITHIN DROPLETS AND OTHER COMPARTMENTS | THE PROCTER & GAMBLE COMPANY (US) | 2016-06-02 | — | — | WO | claimed |
| US-20160145535-A1 | Compositions Comprising Encapsulated Actives within Droplets and other Compartments | THE PROCTER & GAMBLE COMPANY | 2016-05-26 | — | — | US | claimed |
| US-20160130537-A1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2016-05-12 | — | — | US | claimed |
| WO-2014189980-A1 | ENCAPSULATES | PGIOSA (CH) | 2014-11-27 | — | — | WO | claimed |
| EP-2806018-A1 | ENCAPSULATES | The Procter & Gamble Company (US) | 2014-11-26 | — | — | EP | claimed |
| US-20140342972-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2014-11-20 | — | — | US | claimed |
| US-20140338134-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2014-11-20 | — | — | US | claimed |
| EP-0472966-B1 | Esters and their use in perfumery | FIRMENICH & CIE (CH) | 1994-09-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10947483-B2 | Encapsulates | LIPA, TTPA, CHMP4B | CPB2 586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.